Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jaguar Health (JAGX) Long-Term Debt Issuances (2016 - 2025)

Jaguar Health (JAGX) has disclosed Long-Term Debt Issuances for 8 consecutive years, with -$3000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to -$3000.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $3.4 million, a N/A change, with the full-year FY2022 number at $4.0 million, down 63.78% from a year prior.
  • Long-Term Debt Issuances was -$3000.0 for Q2 2025 at Jaguar Health, down from $3.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $11.0 million in Q1 2021 to a low of -$2.0 million in Q3 2022.
  • A 3-year average of $3.7 million and a median of $3.4 million in 2025 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 3035.71% in 2021, then tumbled 45.33% in 2022.
  • Jaguar Health's Long-Term Debt Issuances stood at $11.0 million in 2021, then tumbled by 118.45% to -$2.0 million in 2022, then surged by 99.85% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Long-Term Debt Issuances are -$3000.0 (Q2 2025), $3.4 million (Q1 2025), and -$2.0 million (Q3 2022).